Company / Assets per Share
Myriad Genetics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$8.70
FY2025
5-year range
$8.70 / $18.71
FY2021-FY2025
Trend
-32.3%
vs FY2024
Sector context
#111 of 210
Health Care
What the data says
At $8.70, Myriad Genetics, Inc.'s assets per share ranks #111 of 210 in the Health Care sector. Assets per Share has declined for 6 consecutive years, from $22.62 in FY2019 to $8.70 in FY2025.
Based on SEC 10-K filings.
8.70 in FY2025 with a 5-year CAGR of -15.9%.
Declined from $15.21 to $8.70 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -18.9%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Sector benchmark
#111 of 210 in Health CareTop 53% of 210This company $8.70 Sector average $296.79
▼
-97.1% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s assets per share has declined for 6 consecutive years.
- In FY2025, assets per share decreased 32.3% year-over-year.
- Ranks #111 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.70 | -32.3% |
| FY2024 | $12.85 | -15.5% |
| FY2023 | $15.21 | -6.8% |
| FY2022 | $16.31 | -12.8% |
| FY2021 | $18.71 | -9.8% |
| FY2020 | $20.74 | -8.3% |
| FY2019 | $22.62 | +32.6% |
| FY2018 | $17.06 | +3.7% |
| FY2017 | $16.45 | +50.6% |
| FY2016 | $10.92 | +17.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026